Vivaldis Tocerapet 50mg (Toceranib Phosphate) Targeted Chemotherapy Tablets for Dogs

Select Variant: 1

Description

Provide targeted, advanced oncology care for your dog with Vivaldis Tocerapet 50mg Tablets, available online at PetMitra. Formulated by Vivaldis Animal Health, Tocerapet contains Toceranib Phosphate (50 mg), a veterinary-approved multi-kinase inhibitor that represents the Indian equivalent of the internationally recognized cancer therapy molecule Palladia. Unlike conventional cytotoxic chemotherapy agents that indiscriminately attack all rapidly dividing cells, Tocerapet is a targeted therapeutic agent. It acts on specific receptor tyrosine kinases (RTKs)—including split-kinase family members like c-KIT, VEGFR-2, PDGFR-β, and FLT-3. In canine cancers—especially Mast Cell Tumors (MCTs) where mutations in the c-KIT gene often drive aggressive cellular proliferation—Tocerapet selectively blocks aberrant signaling cascades inside neoplastic cells. Simultaneously, by inhibiting Vascular Endothelial Growth Factor (VEGFR) and Platelet-Derived Growth Factor (PDGFR), Tocerapet exerts potent anti-angiogenic effects, cutting off the microscopic blood vessel supply required for tumor growth and metastatic spread. The 50 mg strength is ideally calibrated for medium-to-large breed dogs requiring precise, weight-calculated dosing schedules.